16108-10-4

Basic information

• Product Name: 2,3,4,9-Tetrahydro-1-methyl-1H-pyrido[3,4-b]indole-3-carboxylic acid methyl ester
• Synonyms: 2,3,4,9-Tetrahydro-1-methyl-1H-pyrido[3,4-b]indole-3-carboxylic acid methyl ester;1-Methyl-2,3,4,9-tetrahydro-1H-beta-carboline-3-carboxylic acid methyl ester
• CAS NO: 16108-10-4
• Molecular Formula: C₁₄H₁₆N₂O₂
• Molecular Weight: 244.29
• Mol File: 16108-10-4.mol
• Article Data: 16

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2,3,4,9-Tetrahydro-1-methyl-1H-pyrido[3,4-b]indole-3-carboxylic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3,4,9-Tetrahydro-1-methyl-1H-pyrido[3,4-b]indole-3-carboxylic acid methyl ester(16108-10-4)
• EPA Substance Registry System: 2,3,4,9-Tetrahydro-1-methyl-1H-pyrido[3,4-b]indole-3-carboxylic acid methyl ester(16108-10-4)

Safety Data

• Hazardous Substances Data: 16108-10-4(Hazardous Substances Data)

Usage

General Description

2,3,4,9-Tetrahydro-1-methyl-1H-pyrido[3,4-b]indole-3-carboxylic acid methyl ester is a chemical compound with potential pharmacological properties. It is a methyl ester derivative of carboxylic acid, which is commonly used in the synthesis of pharmaceutical drugs. 2,3,4,9-Tetrahydro-1-methyl-1H-pyrido[3,4-b]indole-3-carboxylic acid methyl ester has a tetrahydro and methyl group, making it a heterocyclic compound with potential biological activities. It is also known to have a pyridoindole structure, which has been studied for its potential use in the treatment of various medical conditions. Overall, 2,3,4,9-Tetrahydro-1-methyl-1H-pyrido[3,4-b]indole-3-carboxylic acid methyl ester is an important chemical compound with potential pharmaceutical applications.

Upstream product

• 10022-77-2 3-(1H-Indol-3-yl)-2-thioacetylamino-propionic acid methyl ester 
• 10022-77-2 3-(1H-Indol-3-yl)-2-thioacetylamino-propionic acid methyl ester 
• 5470-37-1 1-methyl-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole-3-carboxylic acid 
• 75-07-0 acetaldehyde 
• 7303-49-3 DL-tryptophan methyl ester 
• 4299-70-1 L-tryptophan methyl ester 
• 73-22-3 L-Tryptophan 
• 5619-09-0 methyl tryptophanate hydrochloride 
• 54-12-6 Trp 
• 144605-95-8 methyl 2-nitroso-1-methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxylate 
• 67-56-1 methanol 
• 85239-46-9 1-Methyl-4,9-dihydro-3H-β-carboline-3-carboxylic acid methyl ester; hydriodide 
• 85239-46-9 1-Methyl-4,9-dihydro-3H-β-carboline-3-carboxylic acid methyl ester; hydriodide 

Downstream Products

• 22329-38-0 harman-3-carboxylic acid 
• 1262842-29-4 C₂₁H₂₂N₂O₄S 
• 74914-76-4 3-methoxycarbonyl-1-styryl-β-carbolin 
• 33821-72-6 (1-methyl-9H-pyrido[3,4-b]indol-3-yl)methanol 
• 16641-82-0 1-methyl-β-carboline-3-carboxylic acid methyl ester 

Relevant articles and documents

Harmine-based dual inhibitors targeting histone deacetylase (HDAC) and DNA as a promising strategy for cancer therapy

Overexpression of histone deacetylases (HDACs) are observed in different types of cancers, but histone deacetylase inhibitors (HDACIs) have not shown significant efficacy as monotherapy against solid tumors. Recently, studies demonstrated that it is promi

Tetrahydro-beta-carboline dimer as well as preparation method and application thereof

The invention discloses an application of a tetrahydro-beta-carboline dimer derivative in the preparation of a medicine for preventing or treating Alzheimer's disease. The tetrahydro-beta-carboline dimer derivative is as shown in a structural formula I, which is described in the specification, L-tryptophan and tryptamine are used as raw materials; a tetrahydro-beta-carboline monomer is generated through a Picet-Spengler reaction and aldehyde cyclization, then a tetrahydro-beta-carboline dimer is generated through acyl chloride connection and a click chemical reaction, the synthesis steps are simple, the raw materials are easy to obtain, the yield is high, and the tetrahydro-beta-carboline dimer has remarkable inhibitory activity on butyrylcholine esterase and A[beta]1-42 aggregation. According to the neural protective effect under three AD models on cells, after the cells are independently treated by A[beta]1-42, H2O2 and OA, the survival rate of the cells is low, and apoptosis or necrosis of the cells occurs. The compounds 11, 12, 13, 17 and 19 are used for co-treatment, the compounds 11, 12, 13, 17 and 19 successfully block A[beta]1-42, H2O2 and OA induced cell death, and it is proved that the compounds 11, 12, 13, 17 and 19 have a remarkable neural protective effect.

Pd/C-Catalyzed Dehydrogenative [3+2] Cycloaddition for the Synthesis of Functionalized Tropanes

A Pd/C-catalyzed cascade approach for the synthesis of attractive benzo-fused tropanes was developed. The reaction proceeds through a sequential Pd/C-catalyzed dehydrogenative formation of azomethine ylides from amines and 1,3-dipolar cycloaddition. It allows the generation of structurally complex benzo-fused tropanes in good yields with excellent diastereoselectivities under mild reaction conditions. Preliminary results of asymmetric version of the reaction reveal that the copper catalyst and chiral monophosphoramidite ligand can furnish optically active products with moderate ee.